THURSDAY, April 17, 2025 (HealthDay News) — Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are less likely to achieve quality indicators associated with survival, according to a study published in the April issue of the Journal of the National Comprehensive Cancer Network. Diamantis I. Tsilimigras, […]
The post Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer first appeared on Physician’s Weekly.
